Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography (Q43786564)

26 November 2017

title

Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography (English)

1 reference

26 November 2017

1 reference

1 reference

Goto A

1

1 reference

26 November 2017

Sasai K

2

1 reference

26 November 2017

Suzuki S

3

1 reference

26 November 2017

Fukutomi T

4

1 reference

26 November 2017

Ito S

5

1 reference

26 November 2017

Matsushita T

6

1 reference

26 November 2017

Okamoto M

7

1 reference

26 November 2017

Suzuki T

8

1 reference

26 November 2017

Itoh M

9

1 reference

26 November 2017

Okumura-Noji K

10

1 reference

26 November 2017

Yokoyama S

11

1 reference

26 November 2017

publication date

1 November 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

159

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

153-163

1 reference

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Development of coronary heart disease in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

7 January 2021

CETP and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Heterogeneity at the CETP Gene Locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Plasma lipid transfer activities in hyper-high-density lipoprotein cholesterolemic and healthy control subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

Coronary Plaque Disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900476-2

10.1016/S0021-9150(01)00476-2

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference